DOI: https://doi.org/10.36347/sjams.2024.v12i09.016

Pages: 1211-1215

Drug-induced pancreatitis has been rarely reported. Bortezomib is a selective and reversible proteasome inhibitor used for the treatment of patients with multiple myeloma (MM). We describe the case of a patient with multiple myeloma who developed acute pancreatitis after treatment with bortezomib, commonly used in the treatment of this disease. The patient was admitted to the hospital with symptoms of AP. Common etiological factors of AP were all excluded. The patient was later diagnosed as having bortezomib-induced pancreatitis. We reviewed the available medical literature on this topic and found eleven other similar cases.